ReviewJournal of clinical immunology2023

Modulating the PI3K Signalling Pathway in Activated PI3K Delta Syndrome: a Clinical Perspective.

Lucinda J BerglundPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.